Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051278269> ?p ?o ?g. }
- W2051278269 endingPage "1146" @default.
- W2051278269 startingPage "1146" @default.
- W2051278269 abstract "Follicular thyroid hyperplasia (FTH) refers to enlargement of the thyroid gland due to cellular hyperplasia. It is frequently encountered in clinical practice in nontoxic uninodular or multinodular goiter. The genetic and epigenetic events associated with the origin and malignant potential of FTH are poorly understood.To analyze FTH samples for known recurrent genetic and epigenetic driver events in thyroid neoplasms such as activating mutations in proto-oncogenes BRAF and NRAS and promoter hypermethylation of tumor suppressor genes CDKN2A, PTEN, and RASSF1A.Clinical characteristics and thyroid specimens were prospectively obtained from 43 patients who underwent thyroid surgery at Yale-New Haven Hospital.Presence of BRAF(V600E) and NRAS codon 61 mutations were assessed in FTH. Methylation status of CDKN2A, PTEN, and RASSF1A gene promoters in FTH, follicular thyroid adenoma, and follicular thyroid carcinoma was quantified. Regulation of RASSF1A messenger RNA (mRNA) and protein expression and its potential neoplastic role in FTH were examined.An exploratory cohort of FTH (n = 10) was negative for BRAF(V600E) and NRAS codon 61 mutations. In contrast, epigenetic analysis displayed significant promoter hypermethylation of the tumor-suppressor gene RASSF1A in 6 FTH samples (60%) compared with their adjacent normal tissue (P = .01). The overall genome CpG methylation and promoter methylation of PTEN and CDKN2A were unaffected in the lesions. Further analysis of an expanded cohort of patients with FTH (n = 23), follicular thyroid adenoma (n = 10), and follicular thyroid carcinoma (n = 10) showed RASSF1A promoter hypermethylation in 14 (61%), 9 (90%), and 7 (70%), respectively (P < .001). The overall hypermethylation level in FTH showed a statistically significant inverse correlation with RASSF1A mRNA expression (P = .005). Immunohistochemistry demonstrated minimal or no protein expression in most FTH samples studied. To explore the potential neoplastic contribution of RASSF1A downregulation, we analyzed the expression pattern of thyroid proliferation markers Ki-67 and NF-κB in representative samples. Although Ki-67 expression was undetectable, similar to normal tissue, FTH samples expressed high levels of NF-κB, similar to the expression levels in thyroid tumors.We demonstrate silencing of tumor suppressor RASSF1A in a subset of FTH in the absence of other known thyroid cancer-associated genetic and epigenetic changes. Silencing of RASSF1A and concurrent NF-κB activation demonstrate that a subset of FTH shares epigenetic changes and downstream signaling events associated with malignant lesions, suggesting that FTH may have the potential to be a premalignant lesion." @default.
- W2051278269 created "2016-06-24" @default.
- W2051278269 creator A5023748809 @default.
- W2051278269 creator A5031312217 @default.
- W2051278269 creator A5059198966 @default.
- W2051278269 creator A5062028457 @default.
- W2051278269 creator A5064050509 @default.
- W2051278269 creator A5077986442 @default.
- W2051278269 date "2014-11-01" @default.
- W2051278269 modified "2023-10-03" @default.
- W2051278269 title "Frequent Silencing of RASSF1A via Promoter Methylation in Follicular Thyroid Hyperplasia" @default.
- W2051278269 cites W1839358223 @default.
- W2051278269 cites W1964901367 @default.
- W2051278269 cites W1971205216 @default.
- W2051278269 cites W1976963260 @default.
- W2051278269 cites W1979921882 @default.
- W2051278269 cites W1980839186 @default.
- W2051278269 cites W19898840 @default.
- W2051278269 cites W2005890649 @default.
- W2051278269 cites W2007951368 @default.
- W2051278269 cites W2009300550 @default.
- W2051278269 cites W2017476119 @default.
- W2051278269 cites W2023350298 @default.
- W2051278269 cites W2031351595 @default.
- W2051278269 cites W2033735604 @default.
- W2051278269 cites W2033882181 @default.
- W2051278269 cites W2035974695 @default.
- W2051278269 cites W2038432064 @default.
- W2051278269 cites W2040268038 @default.
- W2051278269 cites W2049150685 @default.
- W2051278269 cites W2057678186 @default.
- W2051278269 cites W2061369198 @default.
- W2051278269 cites W2069392223 @default.
- W2051278269 cites W2069792474 @default.
- W2051278269 cites W2082017108 @default.
- W2051278269 cites W2094943403 @default.
- W2051278269 cites W2098267495 @default.
- W2051278269 cites W2115516953 @default.
- W2051278269 cites W2117852091 @default.
- W2051278269 cites W2135187058 @default.
- W2051278269 cites W2139526606 @default.
- W2051278269 cites W2153595135 @default.
- W2051278269 cites W2157552975 @default.
- W2051278269 cites W2415404874 @default.
- W2051278269 doi "https://doi.org/10.1001/jamasurg.2014.1694" @default.
- W2051278269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25229773" @default.
- W2051278269 hasPublicationYear "2014" @default.
- W2051278269 type Work @default.
- W2051278269 sameAs 2051278269 @default.
- W2051278269 citedByCount "20" @default.
- W2051278269 countsByYear W20512782692015 @default.
- W2051278269 countsByYear W20512782692016 @default.
- W2051278269 countsByYear W20512782692017 @default.
- W2051278269 countsByYear W20512782692018 @default.
- W2051278269 countsByYear W20512782692019 @default.
- W2051278269 countsByYear W20512782692020 @default.
- W2051278269 countsByYear W20512782692021 @default.
- W2051278269 countsByYear W20512782692022 @default.
- W2051278269 countsByYear W20512782692023 @default.
- W2051278269 crossrefType "journal-article" @default.
- W2051278269 hasAuthorship W2051278269A5023748809 @default.
- W2051278269 hasAuthorship W2051278269A5031312217 @default.
- W2051278269 hasAuthorship W2051278269A5059198966 @default.
- W2051278269 hasAuthorship W2051278269A5062028457 @default.
- W2051278269 hasAuthorship W2051278269A5064050509 @default.
- W2051278269 hasAuthorship W2051278269A5077986442 @default.
- W2051278269 hasConcept C104317684 @default.
- W2051278269 hasConcept C121608353 @default.
- W2051278269 hasConcept C124224327 @default.
- W2051278269 hasConcept C126322002 @default.
- W2051278269 hasConcept C142724271 @default.
- W2051278269 hasConcept C150194340 @default.
- W2051278269 hasConcept C190283241 @default.
- W2051278269 hasConcept C190727270 @default.
- W2051278269 hasConcept C21790070 @default.
- W2051278269 hasConcept C2777428134 @default.
- W2051278269 hasConcept C2777609662 @default.
- W2051278269 hasConcept C2779341817 @default.
- W2051278269 hasConcept C2779761222 @default.
- W2051278269 hasConcept C2780265364 @default.
- W2051278269 hasConcept C2780846426 @default.
- W2051278269 hasConcept C2781187634 @default.
- W2051278269 hasConcept C2781461381 @default.
- W2051278269 hasConcept C2993294228 @default.
- W2051278269 hasConcept C33288867 @default.
- W2051278269 hasConcept C41091548 @default.
- W2051278269 hasConcept C502942594 @default.
- W2051278269 hasConcept C526584372 @default.
- W2051278269 hasConcept C526805850 @default.
- W2051278269 hasConcept C54355233 @default.
- W2051278269 hasConcept C71924100 @default.
- W2051278269 hasConcept C86339819 @default.
- W2051278269 hasConcept C86554907 @default.
- W2051278269 hasConcept C86803240 @default.
- W2051278269 hasConceptScore W2051278269C104317684 @default.
- W2051278269 hasConceptScore W2051278269C121608353 @default.
- W2051278269 hasConceptScore W2051278269C124224327 @default.
- W2051278269 hasConceptScore W2051278269C126322002 @default.